medical weight loss with semaglutide Best Way to Lose Weight: Program Semaglutide: A Weight Loss Breakthrough

The trials missed their primary endpoint

making it an important treatment option for type 2 diabetes patients and individuals managing their weight

Primary Endpoint: Weight Loss at 72 Weeks The results were striking and clinically significant: Zepbound Group: Participants achieved an average weight reduction of 20.2% at 72 weeks Wegovy Group: Participants achieved an average weight reduction of 13.7% at 72 weeks Relative Difference: Zepbound provided 47% greater relative weight loss compared to Wegovy To put this in practical terms: A patient weighing 250 pounds could expect to lose approximately 50 pounds with Zepbound versus 34 pounds with Wegovy over the same timeframe

FAQs Is Ozempic insulin